News

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...
But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug approvals.
The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...
In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
AI is changing how drugs are manufactured, particularly when it comes to getting them approved. Because it is so fast at processing information, the whole appro ...
FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...
For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...
AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to revolutionise how drugs are discovered, developed, and deployed.
The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.